Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - Recommendations for a protocol for biochemistry laboratories

Annals of Clinical Biochemistry

Volumn 34, Issue 3, 1997, Pages 222-229

  Wood, P J ^a   Barth, J H ^b   Freedman, D B ^c   Perry, L ^d   Sheridan, B ^e  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Alcoholism; Cortisol; Depression; Obesity

Indexed keywords

ALCOHOL; DEXAMETHASONE; ESTROGEN; HYDROCORTISONE; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN; TAMOXIFEN;

AGING; ANALYTIC METHOD; CLINICAL CHEMISTRY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUSHING SYNDROME; DEPRESSION; DRUG BLOOD LEVEL; DRUG CLEARANCE; HEMODIALYSIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOASSAY; KIDNEY FAILURE; META ANALYSIS; OBESITY; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SEASONAL VARIATION; STRESS; WEIGHT REDUCTION;

EID: 0030961307     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329703400302     Document Type: Review

References (48)

1. Pugeat MM, Dunn JF, Nisula BC. Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 69-75
2. Liddle GW. Tests of pituitary adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1960; 20: 1539-60
3. Nugent CA, Nichols T, Tyler FH. Diagnosis of Cushing's syndrome-single dose dexamethasone suppression test. Arch Int Med 1965; 116: 172-6
4. Nichols T, Nugent CA, Taylor FH. Steroid laboratory tests in the diagnosis of Cushing's syndrome. Am J Med 1968; 45: 116-28
5. Barth J, Seth J, Hewlett TA, Freedman DB. A survey of endocrine function testing by clinical biochemistry laboratories in the UK. Ann Clin Biochem 1995; 32: 442-9
6. Carroll BJ. The dexamethasone test for melancholia. Br J Psychiat 1982; 140: 292
7. Brown WA, Haser RJ, Quails CB. Dexamethasone suppression test identifies subtypes of depression which respond to different anti-depressants. Lancet 1980; i: 928
8. Peselow ED, Fieve RR. Dexamethasone suppression test and response to anti-depressants in depressed patients. N Engl J Med 1982; 19: 1216
9. Meikle AW. Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol 1982; 16: 401-8
10. Shimizu N, Yoshida H. Studies on "low dose" suppressible Cushing's disease. Endocrinol Japon 1976; 23: 479-84
11. Odagiri E, Demura R, Demura H, Suda T, Ishiwatari N, Abe Y, et al. The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing's disease. Endocrinol Japon 1988; 35: 795-802
12. Crapo L. Cushing's syndrome: A review of diagnostic tests. Metabolism 1979; 28: 955-77
13. Weiner MF. Age and cortisol suppression by dexamethasone in normal subjects. J Psychiat Res 1989; 23: 163-8
14. Jubiz W, Meikle AW, Levinson RA, Mizutani S, West CD, Tyler FH. Effect of diphenylhydantoin on the metabolism of dexamethasone in humans. N Engl J Med 1970; 283: 11-14
15. Rush AJ, Schlesser MA, Giles DE, Crowley GT, Fairchild C, Attshuler KZ. The effect of dosage on the dexamethasone test in normal controls. Psychiat Res 1982; 7: 277-85
16. Tiller JW, Maguire KP, Schweitzer I, Biddle N, Campbell DG, Outch K, et al. The dexamethasone suppression test: a study in a normal population. Psychoneuroendocrinology 1988; 13: 377-84
17. Fok ACK, Tan KT, Jacob E, Sum CF. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-Cushingoid obesity from Cushing's syndrome. Steroids 1991; 56: 549-51
18. Cronin C, Igoc I, Duffy MJ, Cunningham SK, McKenna TJ. The overnight dexamethasone test is a worthwhile screening procedure. Clin Endocrinol 1990; 33: 27-33
19. Edelstein CK, Roy-Byrne P, Fawzy FI, Dornfield L. Effects of weight loss on the dexamethasone suppression test. Am J Psychiat 1983; 140: 338-41
20. Reschini E, Giustina G. Clinical experience with a simple screening test for Cushing's syndrome combining the determination of plasma cortisol circadian rhythm with the overnight dexamethasone suppression test. Am J Med Sci 1978; 275: 33-42
21. O'Brien JT, Schweitzer I, Ames D, Tuckwell V, Mastwyk M. Cortisol suppression by dexamethasone in the healthy elderly: effects of age, dexamethasone levels and cognitive function. Biol Psychiat 1994; 36: 389-94
22. Mendiewicz J, Charles G, Franckson JM. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups. Br J Psychiat 1982; 141: 464-70
23. Haier RJ, Kestner GI. Sensitivity and specificity of 1 and 2 mg dexamethasone suppression tests. Psychiat Res 1982; 7: 271-6
24. Whalley LJ, Borthwick N, Copolov D, Dick H, Christie JE, Fink G. Glucocorticoid receptors and depression. BMJ 1986; 292: 859-61
25. Lampe TH, Fariss BL, Risse SC, Raskind MA, Plymate SR. Laboratory evaluation for Cushing's syndrome in psychiatric patients with cortisol non-suppression following the overnight dexamethasone suppression test. Biol Psychiat 1987; 22: 1264-70
26. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, et al. Responses to corlicotrophin releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 1986; 314: 1329-35
27. Connolly CK, Gore MBR, Stanley W, Willis MR. Single dose dexamethasone suppression in normal subjects and hospitalised patients. BMJ 1965; 21: 665-7
28. Rees LH, Besser GM, Jeffcoate WJ, Goldie DJ, Marks V. Alcohol-induced Cushing's syndrome. Lancet 1977; i: 726-30
29. Newsom G, Murray N. Reversal of dexamethasone suppression test non-suppression in alcohol abusers. Am J Psychiat 1983; 140: 353-4
30. Ramirez G, Gomez-Sanchez C, Meikle WA, Jubiz W. Evaluation of the hypothalamic-hypophyseal-adrenal axis in patients receiving long-term haemodialysis. Ann Intern Med 1982; 142: 1448-52
31. Workman RJ, Vaughn WK, Stone WJ. Dexamethasone suppression testing in chronic renal failure. Pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 1986; 63: 741-6
32. Haigh SE, Tevaarwerk GJ. A rise in the glomerular filtration rate as a cause of a "paradoxical" increase in urinary free cortisol during dexamethasone suppression in a patient with an adrenal adenoma: a case report. Clin Endocrinol 1981; 15: 53-6
33. Brown RD, Van Loon GR, Orth DN, Liddle GW. Cushing's disease with periodic hormonogenesis. One explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab 1973; 36: 445-51
34. Liberman B, Wajchenberg B, Tambascia MA, Mesquita CH. Periodic remission in Cushing's disease with paradoxical dexamethasone response: An expression of periodic hormonoeencsis. J Clin Endocrinol Metab 1976; 43: 913-8
35. Atkinson AB, Kennedy AL, Carson DJ, Hadden DR, Weaver JA, Sheridan B. Five cases of cyclical Cushing's syndrome. BMJ 1985; 291: 1453-9
36. Monteleone P, Piccolo A, Martino M, Maj M. Seasonal variation in the dexamethasone test: a longitudinal study in chronic schizophrenics and in healthy subjects. Neuropsychobiology 1994; 30: 61-5
37. Yerevanian BI, Anderson JL, Milanese E. Effect of weekly testing on dexamethasone suppression test results in normal subjects. Psychiat Res 1985; 14: 209-13
38. Kennedy L, Atkinson AB, Johnston M, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome. BMJ 1984; 289: 1188-91
39. McHardy-Young S, Harris PWR, Lessof MH, et al. Single dose dexamethasone suppression test for Cushing's syndrome. BMJ 1967; 2: 740-4
40. Seidensticker JF, Folk RC, Wieland RG, Hamwi GJ. Screening test for Cushing's syndrome with plasma 11-hydroxycorticosteroids. J Am Med Soc 1967; 202: 87-90
41. Nishida S, Matsumura S, Horino M, Oyama H, Tenku A. Single dose four hour dexamethasone suppression test in normal men and ils application for the diagnosis of Cushing's syndrome. Steroids 1976; 28: 411-21
42. Hindmarsh PC, Brook CG. Single dose dexamethasone suppression test in children: dose relationship to body size. Clin Endocrinol 1985; 23: 67-70
43. Atkinson AB, McAteer EJ, Hadden DR, Kennedy AL, Sheridan B, Traub AI. A weight-related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome. Acta Endocrinol 1989; 120: 753-9
44. James VHT, Landon J. Hypothalamic-Pituitary-Adrenal Function Tests: A Working Guide For Clinicians and Laboratory Staff. London: Cambridge University Press, 1968
45. Blethen SL, Chasalow FI. Overnight dexamethasone suppression test: normal responses and the diagnosis of Cushing's syndrome. Steroids 1989; 54: 185-93
46. Montwill J, Igoe D, McKenna TJ. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Steroids 1994; 59: 296-8
47. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M. A sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol 1995; 43: 545-50
48. Hankin ME, Theale HM, Steinbeck AW. An evaluation of laboratory tests for the detection and differential diagnosis of Cushing's syndrome. Clin Endocrinol 1977; 6: 185-96